{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:02:04Z","timestamp":1761102124380},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00381-014-2541-1","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T08:20:00Z","timestamp":1411028400000},"page":"2109-2114","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genetic analysis of the UPB1 gene in two new Chinese families with \u03b2-ureidopropionase deficiency and the carrier frequency of the mutation c.977G&gt;A in Northern China"],"prefix":"10.1007","volume":"30","author":[{"given":"Jianbo","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiqian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingtao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiming","family":"Situ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiquan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"issue":"7","key":"2541_CR1","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbadis.2012.04.001","volume":"1822","author":"AB Kuilenburg van","year":"2012","unstructured":"van Kuilenburg AB, Dobritzsch D, Meijer J, Krumpel M, Selim LA, Rashed MS, Assmann B, Meinsma R, Lohkamp B, Ito T, Abeling NG, Saito K, Eto K, Smitka M, Engvall M, Zhang C, Xu W, Zoetekouw L, Hennekam RC (2012) \u00df-Ureidopropionase deficiency: phenotype, genotype and protein structural consequences in 16 patients. Biochim Biophys Acta 1822(7):1096\u20131108","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"2541_CR2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/FPC.0b013e3282f01788","volume":"17","author":"HR Thomas","year":"2007","unstructured":"Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB (2007) Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism. Pharmacogenet Genomics 17(11):973\u2013987","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"2541_CR3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jms.1500","volume":"44","author":"T Kuhara","year":"2009","unstructured":"Kuhara T, Ohse M, Inoue Y, Shinka T (2009) Five cases of beta-ureidopropionase deficiency detected by GC\/MS analysis of urine metabolome. J Mass Spectrom 44(2):214\u2013221","journal-title":"J Mass Spectrom"},{"issue":"22","key":"2541_CR4","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/hmg\/ddh303","volume":"13","author":"AB Kuilenburg van","year":"2004","unstructured":"van Kuilenburg AB, Meinsma R, Beke E, Assmann B, Ribes A, Lorente I, Busch R, Mayatepek E, Abeling NG, van Cruchten A, Stroomer AE, van Lenthe H, Zoetekouw L, Kulik W, Hoffmann GF, Voit T, Wevers RA, Rutsch F, van Gennip AH (2004) \u00df-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. Hum Mol Genet 13(22):2793\u20132801","journal-title":"Hum Mol Genet"},{"key":"2541_CR5","doi-asserted-by":"crossref","unstructured":"Nakajima Y, Meijer J, Dobritzsch D, Ito T, Meinsma R, Abeling NG, Roelofsen J, Zoetekouw L, Watanabe Y, Tashiro K, Lee T, Takeshima Y, Mitsubuchi H, Yoneyama A, Ohta K, Eto K, Saito K, Kuhara T, van Kuilenburg AB (2014) Clinical, biochemical and molecular analysis of 13 Japanese patients with \u03b2-ureidopropionase deficiency demonstrates high prevalence of the p.977G\u2009>\u2009A (p.R326Q) mutation. J Inherit Metab Dis 14[Epub ahead of print]","DOI":"10.1007\/s10545-014-9754-z"},{"issue":"2\u20133","key":"2541_CR6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0167-4781(99)00182-7","volume":"1447","author":"P Vreken","year":"1999","unstructured":"Vreken P, van Kuilenburg AB, Hamajima N, Meinsma R, van Lenthe H, G\u00f6hlich-Ratmann G, Assmann BE, Wevers RA, van Gennip AH (1999) cDNA cloningg, genomic structure and chromosomal localization of the human BUP-1 gene encoding beta- ureidopropionase. Biochim Biophys Acta 1447(2\u20133):251\u2013257","journal-title":"Biochim Biophys Acta"},{"key":"2541_CR7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3177\/jnsv.47.132","volume":"47","author":"T Sakamoto","year":"2001","unstructured":"Sakamoto T, Sakata SF, Matsuda K, Horikawa Y, Tamaki N (2001) Expression and properties of human liver beta-ureidopropionase. J Nutr Sci Vitaminol (Tokyo) 47:132\u2013138","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"3","key":"2541_CR8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1124\/mol.56.3.464","volume":"56","author":"V Schmieden","year":"1999","unstructured":"Schmieden V, Kuhse J, Betz H (1999) A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition. Mol Pharmacol 56(3):464\u2013472","journal-title":"Mol Pharmacol"},{"issue":"4","key":"2541_CR9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jnr.10012","volume":"66","author":"S K\u00f6lker","year":"2001","unstructured":"K\u00f6lker S, Okun JG, H\u00f6rster F, Assmann B, Ahlemeyer B, Kohlm\u00fcller D, Exner-Camps S, Mayatepek E, Krieglstein J, Hoffmann GF (2001) 3-ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis. J Neurosci Res 66(4):666\u2013673","journal-title":"J Neurosci Res"},{"key":"2541_CR10","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/oby.2008.337","volume":"16","author":"K Begriche","year":"2008","unstructured":"Begriche K, Massart J, Abbey-Toby A, Igoudjil A, Lett\u00e9ron P, Fromenty B (2008) Beta-aminoisobutyric acid prevents dietinduced obesity in mice with partial leptin deficiency. Obesity (Silver Spring) 16:2053\u20132067","journal-title":"Obesity (Silver Spring)"},{"key":"2541_CR11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1472-8206.2009.00765.x","volume":"24","author":"K Begriche","year":"2010","unstructured":"Begriche K, Massart J, Fromenty B, Begriche K, Massart J, Fromenty B (2010) Effects of \u03b2-aminoisobutyric acid on leptin production and lipid homeostasis: mechanisms and possible relevance for the prevention of obesity. Fundam Clin Pharmacol 24:269\u2013282","journal-title":"Fundam Clin Pharmacol"},{"key":"2541_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2006-923933","volume":"37","author":"B Assmann","year":"2006","unstructured":"Assmann B, G\u00f6hlich G, Baethmann M, Wevers RA, Van Gennip AH, Van Kuilenburg AB, Dietrich C, Wagner L, Rotteveel JJ, Schaper J, Mayatepek E, Hoffmann GF, Voit T (2006) Clinical findings and a therapeutic trial in the first patient with beta-ureidopropionase deficiency. Neuropediatrics 37:20\u201325","journal-title":"Neuropediatrics"},{"key":"2541_CR13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/FPC.0b013e3282f2f134","volume":"18","author":"HR Thomas","year":"2008","unstructured":"Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB (2008) Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism. Pharmacogenet Genomics 18:25\u201335","journal-title":"Pharmacogenet Genomics"},{"key":"2541_CR14","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1734-1140(12)70919-2","volume":"64","author":"J Fidlerova","year":"2012","unstructured":"Fidlerova J, Kleiblova P, Kormunda S, Novotny J, Kleibl Z (2012) Contribution of the b-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity. Pharmacol Rep 64:1234\u20131242","journal-title":"Pharmacol Rep"},{"key":"2541_CR15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1023\/A:1005338230321","volume":"20","author":"AH Gennip van","year":"1997","unstructured":"van Gennip AH, van Lenthe H, Abeling NG, Scholten EG, van Kuilenburg AB (1997) Inhibition of b-ureidopropionase by propionate may contribute to neurological complications in patients with propionic acidemia. J Inherit Metab Dis 20:379\u2013382","journal-title":"J Inherit Metab Dis"},{"key":"2541_CR16","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jms.354","volume":"37","author":"M Ohse","year":"2002","unstructured":"Ohse M, Matsuo M, Ishida A, Kuhara T (2002) Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic\/mass spectrometric analysis of urine. J Mass Spectrom 37:954\u2013962","journal-title":"J Mass Spectrom"},{"key":"2541_CR17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/clinchem\/39.3.380","volume":"39","author":"AH Gennip van","year":"1993","unstructured":"van Gennip AH, Busch S, Elzinga L, Stroomer AE, van Cruchten A, Scholten EG, Abeling NG (1993) Application of simple chromatographic methods for the diagnosis of defects in pyrimidine degradation. Clin Chem 39:380\u2013385","journal-title":"Clin Chem"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-014-2541-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-014-2541-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-014-2541-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T16:13:41Z","timestamp":1598285621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-014-2541-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2541"],"URL":"https:\/\/doi.org\/10.1007\/s00381-014-2541-1","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]}}}